Methods of using interleukin-2 agents
US12098178B2 · kind B2 · utility
0Cited by
41References
31Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 3, 2021 |
| Grant date | Sep 24, 2024 |
| Priority date | — |
| Expiry date | Dec 3, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
IL-2 agents that comprise IL-2 variants are disclosed as well as methods, compositions, and uses thereof. The IL-2 agents described herein can be used to treat and/or prevent various disorders and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.